Allergen immunotherapy on the way to product-based evaluation—a WAO statement

Allergen immunotherapy (AIT) is widely used in clinical practice for patients with moderate to severe allergic rhinitis due to inhalant allergens and may be delivered via subcutaneous (SCIT) and sublingual routes (SLIT). However, the quality of evidence for individual AIT products is very heterogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachert, Claus, Larché, Mark, Bonini, Sergio, Canonica, Giorgio Walter, Kündig, Thomas, Larenas-Linnemann, Desiree, Ledford, Dennis, Neffen, Hugo, Pawankar, Ruby, Passalacqua, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571059/
https://www.ncbi.nlm.nih.gov/pubmed/26417398
http://dx.doi.org/10.1186/s40413-015-0078-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571059/
https://www.ncbi.nlm.nih.gov/pubmed/26417398
http://dx.doi.org/10.1186/s40413-015-0078-8

Ejemplares similares